3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Specimen Handling
6
Cytarabine
6
fludarabine
5
Biopsy
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Cyclophosphamide
4
venetoclax
3
decitabine and cedazuridine drug combination
3
Mycophenolic Acid
3
Melphalan
3
Injections
3
Idarubicin
3
CPX-351
3
Busulfan
3
Blood Specimen Collection
3
ruxolitinib
2
nilotinib
2
luspatercept
2
ivosidenib
2
asciminib
2
Thiotepa
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Liposomes
2
Gemtuzumab
2
Filgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.